Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Acta Biomaterialia is Scopus-indexed (Q1, CiteScore 17.7), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Acta Materialia Inc.
Checked against the index lists dated .
ISSN 1742-7061Verify ISSN ↗1878-7568Verify ISSN ↗
Publisher: Acta Materialia Inc
Cost to publish: About US$3,810 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Biochemistry | 20 / 448 | 95th | Q1 |
| Biotechnology | 16 / 325 | 95th | Q1 |
| Biomedical Engineering | 20 / 342 | 94th | Q1 |
| Molecular Biology | 27 / 414 | 93rd | Q1 |
| Biomaterials | 13 / 146 | 91st | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2005–present, best quartile Q1, CiteScore 17.7.
Acta Biomaterialia is Q1 in Biochemistry (rank 20 of 448), Q1 in Biotechnology (rank 16 of 325) and Q1 in Biomedical Engineering (rank 20 of 342), by CiteScore 2025. It is ranked in 5 subject areas in all.
Acta Biomaterialia is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 17.7, which places it in quartile Q1 at the 95th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 1.884, quartile Q1, with an H-index of 278.
The publisher lists an article processing charge of about US$3,810 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Acta Biomaterialia is published by Acta Materialia Inc. Its print ISSN is 1742-7061 and its online ISSN is 1878-7568.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Acta Biomaterialia has an h-index of 298 and a 2-year mean of 9.15 citations per paper (OpenAlex). Its Scopus CiteScore is 17.7, quartile Q1. On 2-year citations it ranks #17 of 442 Scopus journals in Biochemistry.
Acta Biomaterialia published 765 papers in 2025. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 98 research articles (2026), authors are most often from China (47.3%), United States (23.3%) and Germany (3.4%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. 31 retracted papers are recorded (2.7 per 1,000 papers). The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.